在造血细胞移植中的HLA结构和功能
1Division of Translational Science and Therapeutics, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Best practice & research. Clinical haematology
|October 13, 2024
概括
人类白细胞抗原 (HLA) 兼容性是输血细胞移植的关键. 新的研究揭示了影响移植成功的非HLA遗传因素,建议修订供体选择策略以获得更好的结果.
科学领域:
- 免疫遗传学 免疫遗传学
- 移植免疫学 移植免疫学
背景情况:
- 超过50年来,人类白细胞抗原 (HLA) 匹配一直是异性造血细胞移植中供体选择的核心.
- 这大大提高了对HLA免疫生物学的理解.
研究的目的:
- 探索超出HLA匹配影响移植结果的新型遗传因素.
- 根据新出现的证据,提出新的供体选择模型.
主要方法:
- 研究了患者和捐赠者的生殖系变异.
- 分析了HLA分子的新型非编码多态和结构/表达特征.
- 检查了HLA连接体和捐赠NK受体的对效应.
主要成果:
- 鉴定出具有独立于HLA匹配的临床后果的生殖系变异.
- 发现了新的非编码多态和HLA分子特征,影响了移植结果.
- 突出了HLA连接体/捐赠者NK受体相互作用在调节免疫反应中的作用.
结论:
- 供体选择可能会从考虑传统HLA兼容性以外的因素中获益.
- 了解非编码变异和NK细胞相互作用为改善移植成功提供了新的途径.
- 对这些元素的进一步研究可以导致临床上可翻译的工具.
相关概念视频
Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
Cell-mediated Immune Responses
67.5K
Overview
67.5K
Bone Marrow Sampling and Transplants
312
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
312
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
T Cell Activation and Clonal Selection
679
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
679


